Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × ponatinib × Clear all

Phase

Status

Sponsor Class

OTHER 36 INDUSTRY 13 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1

Interventions

Cyclophosphamide 333 Specimen Handling 315 Magnetic Resonance Spectroscopy 268 Radiotherapy 264 Biopsy 233 Cisplatin 216 Carboplatin 205 Doxorubicin 190 Paclitaxel 186 Fluorouracil 173 Etoposide 171 Vincristine 158 Bevacizumab 154 Filgrastim 150 Gemcitabine 139 Leucovorin 130 Cytarabine 128 aldesleukin 121 Docetaxel 103 fludarabine phosphate 98 Rituximab 96 Taxes 95 Oxaliplatin 95 Chemotherapy, Adjuvant 95 Prednisone 89 Irinotecan 89 Radiation 88 Methotrexate 87 Bortezomib 87 Dexamethasone 85

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01838642 2017-02-15

Ponatinib for Advanced Medullary Thyroid Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated

3 enrolled 13 charts

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡